JL

Julien LEFRANC

BP Bayer Pharma: 9 patents #91 of 819Top 15%
BH Bayer Healthcare: 2 patents #3,312 of 8,007Top 45%
DK Deutsches Krebsforschungszentrum: 2 patents #74 of 345Top 25%
Overall (All Time): #556,016 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11529356 2-(morpholin-4-yl)-1,7-naphthyridines Lars Wortmann, Ulrich Lücking, Hans Briem, Marcus Koppitz, Knut Eis +10 more 2022-12-20
11524944 2-phenylpyrimidine-4-carboxamides as AHR inhibitors Norbert Schmees, Ulrike Röhn, Ludwig Zorn, Judith Günther, Ilona GUTCHER +4 more 2022-12-13
11304946 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists Norbert Schmees, Ulrike Röhn, Ludwig Zorn, Judith Günther, Ilona GUTCHER +4 more 2022-04-19
10894784 Heteroarylbenzimidazole compounds Volker Schulze, Tobias Heinrich, Florian Prinz, Jens SCHRÖDER, Anne Mengel +13 more 2021-01-19
10772893 2-(morpholin-4-yl)-1,7-naphthyridines Lars Wortmann, Ulrich Lücking, Hans Briem, Marcus Koppitz, Knut Eis +10 more 2020-09-15
10729680 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines Ulrich Lücking, Marcus Koppitz, Lars Wortmann, Antje Margret Wengner, Gerhard Siemeister +4 more 2020-08-04
10487092 Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors Anja GIESE, Ulrich Klar, Keith Graham, Georg Kettschau, Detlev Sülzle +3 more 2019-11-26
9993484 2-(morpholin-4-yl)-1,7-naphthyridines Lars Wortmann, Ulrich Lücking, Hans Briem, Marcus Koppitz, Knut Eis +10 more 2018-06-12
9549932 2-(morpholin-4-yl)-1,7-naphthyridines Lars Wortmann, Ulrich Lücking, Hans Briem, Franz VON NUSSBAUM, Benjamin Bader +10 more 2017-01-24